Holen Sie sich die Stockscreener-App
0.2071
0.15%
0.0003
Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten
Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update - Defense World
Vincerx Pharma announces workforce reduction of 55%, cost-control measures - Yahoo Finance
VINC Stock Touches 52-Week Low at $0.24 Amid Market Challenges - Investing.com UK
Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Asianet Newsable
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of Vip943 - Marketscreener.com
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 - GlobeNewswire
Vincerx Pharma Reports Promising Cancer Drug Results, Explores Strategic Options Amid Cost Cuts - StockTitan
Vincerx Pharma gets extension to meet Nasdaq listing criteria - Investing.com
Vincerx Pharma gets extension to meet Nasdaq listing criteria By Investing.com - Investing.com UK
Leerink Partnrs Weighs in on Vincerx Pharma FY2024 Earnings - Defense World
ARMISTICE CAPITAL, LLC Expands Stake in Vincerx Pharma Inc - GuruFocus.com
Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - Quartz
Prosight Management, LP Reduces Stake in Vincerx Pharma Inc - GuruFocus.com
Vincerx Pharma Reports Q3 2024 Financial Results - TipRanks
Vincerx Pharma Inc reports results for the quarter ended September 30Earnings Summary - XM
Vincerx Pharma Reports Third Quarter 2024 Financial Results - GlobeNewswire
Vincerx Pharma Reports Complete Responses in VIP943 Trial, Narrows Q3 Loss to $0.17/Share | VINC Stock News - StockTitan
VINC stock touches 52-week low at $0.32 amid market challenges - Investing.com Canada
SEC Form PRE 14A filed by Vincerx Pharma Inc. - Quantisnow
VINC Stock on the Rise: A Promising Investment - The InvestChronicle
Should investors be concerned about Vincerx Pharma Inc (VINC)? - US Post News
Financial Health Check: Examining Vincerx Pharma Inc (VINC)’s Key Ratios - The Dwinnex
What Makes Vincerx Pharma (VINC) a New Buy Stock - Yahoo Finance
Check Out Vincerx Pharma Inc (VINC)’s Trade Data Rather Than the Analysts’ Views - SETE News
Taking a Closer Look At Vincerx Pharma Inc (VINC) Following Its Recent Trade - Knox Daily
VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges By Investing.com - Investing.com South Africa
VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges - Investing.com
Wall Street Analyst Initiated Vincerx Pharma Inc [VINC]. What else is Wall St. saying - The DBT News
Vincerx stock tumbles 20% on corporate updates - MSN
Vincerx Pharma Inc (VINC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Leerink Partners Cuts Vincerx Pharma (NASDAQ:VINC) Price Target to $2.00 - Defense World
Vincerx reports two complete responses in VIP943 study By Investing.com - Investing.com Australia
VINC’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Vincerx stock tumbles 20% on corporate updates (NASDAQ:VINC) - Seeking Alpha
Leerink cuts Vincerx Pharma stock target on pipeline update By Investing.com - Investing.com UK
Financial Fitness Check: Examining Vincerx Pharma Inc (VINC)’s Key Ratios - The Dwinnex
Vincerx reports two complete responses in VIP943 study - Investing.com
Vincerx Reports Positive Initial Clinical Data from Ongoing - GlobeNewswire
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates - StockTitan
Why Is Cancer Focused Penny Stock Vincerx Pharma Trading Higher Today? - MSN
Vincerx Pharma (NASDAQ:VINC) Trading Down 2.1% - Defense World
A better buy-in window may exist right now for Vincerx Pharma Inc (VINC) - SETE News
Investing in Vincerx Pharma Inc (VINC) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely - Simply Wall St
Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky - Yahoo Finance
Vanguard Group Inc. Has $3.38 Million Position in Vincerx Pharma, Inc. (NASDAQ:VINC) - Defense World
Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval - TipRanks
VINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024 - MSN
Vincerx Pharma Reports Second Quarter 2024 Financial Results - GlobeNewswire
Acadian Asset Management LLC Sells 36,571 Shares of Vincerx Pharma, Inc. (NASDAQ:VINC) - Defense World
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Decreases By 31.7% - Defense World
How should investors view Vincerx Pharma Inc (VINC)? – US Post News - US Post News
Vincerx Pharma Inc (VINC) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Down 29.3% in June - Defense World
Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts? - Yahoo Finance
Vincerx Pharma Inc Inc. (VINC) Price Performance: A Technical Analysis Perspective - The InvestChronicle
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):